PALO ALTO, Calif., April 27, 2021 /PRNewswire/ -- Varian (NYSE:
VAR), a Siemens Healthineers company, has signed an agreement with
Australia's Icon Group to provide
30 linear accelerators and associated treatment software to help
tackle the growing global cancer burden. This agreement further
strengthens the global partnership between Varian and Icon Group,
together increasing access to care across regional and
underserviced areas in Australia
and Asia.
The order is comprised of a variety of Varian linear
accelerators and software including Halcyon™, TrueBeam®, and
HyperArc™. These systems will be installed in new and existing Icon
cancer centers in Australia to
increase capacity and broaden patient access, as well as in cancer
centers in Singapore and
China.
"We are extremely proud of our global partnership with Varian,
which continues to help meet our long-term goal of increasing
access to care. This investment helps to address the cancer burden
in rural and regional Australia
and underserved communities in Singapore and China," said Mark
Middleton, CEO of Icon Group. "It's great to see progress
being made on the path to a world where cancer is no longer a
burden; where people have every opportunity to fight cancer no
matter where they live."
Icon continues to play a paramount role in the development of
radiation oncology treatments and has been an early adopter of
Varian technologies over the years, including the first in
Australasia to install the Varian Halcyon radiotherapy system and
first in Australia to install and treat with HyperArc
technology – benefitting patients with multiple tumors in the
brain. Icon Group is also a member of the Varian Adaptive
Intelligence™ Consortium, alongside other international
institutions, to collaboratively develop clinical and technical
aspects of Ethos™ therapy and wider radiation therapy treatments
and techniques that will continue to evolve cancer care.
"We are honored to be selected once again by Icon Group to
provide Varian radiotherapy and radiosurgery systems for its cancer
centers around the world," said Chris
Toth, CEO, Varian, a Siemens Healthineers company. "As the
cancer burden continues to rise, we are proud to work with our
global partners at Icon Group to expand access to advanced cancer
care to achieve a world without fear of cancer."
About Varian
At Varian, a Siemens Healthineers
company, we envision a world without fear of cancer. For more than
70 years, we have developed, built and delivered innovative cancer
care technologies and solutions for our clinical partners around
the globe to help them treat millions of patients each year. With
an Intelligent Cancer Care approach, we are harnessing advanced
technologies like artificial intelligence, machine learning and
data analytics to enhance cancer treatment and expand access to
care. Our 11,000 employees across 70 locations keep the patient and
our clinical partners at the center of our thinking as we power new
victories in cancer care. Because, for cancer patients everywhere,
their fight is our fight. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Lynne
Tran
Corporate Communications
publicrelations@varian.com
Investor Relations Contact
Siemens Healthineers
Investor Relations
View original
content:http://www.prnewswire.com/news-releases/varian-and-icon-group-partner-to-extend-commitment-to-global-cancer-care-301278361.html
SOURCE Varian